Search
for
Sort by
Research 61–90 of 1000+
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib
- Tofacitinib treatment in a severe pediatric alopecia areata: A case report and a literature review
- 164 Epigenetic and transcriptional profiling of PBMCs in mild and severe alopecia areata using single-cell RNA-Seq and ATAC-Seq
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser
- Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case series
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report
- A Paediatric Case of Severe Allergic Conjunctivits with Underlying Alopecia Areata
- Alopecia areata after severe allergic contact dermatitis to a permanent hair dye
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Efficacy and tolerability of methotrexate in severe childhood alopecia areata
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Tofacitinib therapy for children with severe alopecia areata
- Ruxolitinib for the treatment of severe alopecia areata
- Immunohistochemical Characterization of the Cellular Infiltrate in Severe Alopecia areata before and after Minoxidil Treatment
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: A Retrospective Study
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials